Doctors miss >50% of the life-threatening complications of pregnancy. We are an ML platform that integrates into the EHR to flag high-risk patients as early as their 1st visit, so doctors can intervene months before delivery.
Over 80% of cases of maternal mortality are preventable with earlier intervention (CDC). Risk assessments in the status quo have low high-risk detection rates, which hurt a doctor’s ability to administer preventative care and ensure safe, healthy deliveries.
Doctors currently miss more than 50% of patients who have life-threatening complications and wait until labor to start doing manual risk assessments, at which point it's too late.
Each of these complications cost providers between $3K-15K per case and can cost payors up to $75k per case.
These major pregnancy complications cost insurers >$55B annually!
📚Quick Quiz: Hemorrhage (excessive bleeding) is the #1 killer of moms during labor. What percent of all moms that hemorrhage do you think doctors currently identify as high risk?
✔️Answer: 22%. Yep, in 2023, doctors have to manually tabulate a risk assessment when patients are on the delivery bed and still fail to classify >75% of hemorrhage cases as high risk. Elythea catches 2x-3x more hemorrhaging patients as early as the first visit, evolving over the course of a pregnancy with patient visits.
Earlier intervention and improved clinical preparation have been shown to prevent nearly two-thirds of severe maternal complications. Elythea's ML models flag high-risk patients as soon as the first visit and evolve over the course of a pregnancy.
We automatically analyze relevant demographic and clinical risk factors, flag high-risk patients, and provide evidence-based interventions, giving doctors weeks to months in advance to intervene and prevent complications from ever happening.
We predict risk for conditions like postpartum hemorrhage, preeclampsia/eclampsia, emergency C-section, preterm labor, and more.
We have completed prospective international clinical studies across USA, Cameroon, and Nigeria demonstrating that our models have better performance than current gold-standard clinical tools. Our global clinical studies have shown that we can catch 2-3x more moms with complications than current clinical risk assessments >10x sooner.
Reetam was on the medical school track to be a high-risk obstetrician and read all the standard OBGYN medical textbooks. He came across this problem after interviewing 80+ obstetric providers, where the vast majority pointed him toward the direction of postpartum hemorrhage and hypertensive complications.
Reetam previously founded Junior Medical Academy, a global medical education nonprofit accessible to students across 30+ countries, and Survivor Central, a national platform matching survivors of sexual assault/domestic violence with medical/legal/financial resources. He has 1st authored >15 accepted medical publications, including in multiple Nature Journals. He studied cancer engineering at Brown and left medical school to work on Elythea full-time.